Division of Molecular Cardiology, Research Institute of Angiocardiology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.
J Cereb Blood Flow Metab. 2012 Feb;32(2):341-52. doi: 10.1038/jcbfm.2011.132. Epub 2011 Sep 28.
Increased vascular smooth muscle contractility has an important role in the development of cerebral vasospasm after subarachnoid hemorrhage (SAH). Myofilament Ca(2+) sensitivity is a major determinant of smooth muscle contractility. We investigated changes in the Ca(2+)-sensitizing effect of endothelin-1 (ET-1) and the mechanisms underlying ET-1-induced Ca(2+) sensitization after SAH using a rabbit SAH model. After SAH, the contractile response to ET-1 was enhanced, and the ET(A) receptor expression was upregulated in the basilar artery. In α-toxin-permeabilized preparations, ET-1 induced enhanced and prolonged contraction after SAH, suggesting that ET-1-induced Ca(2+) sensitization is potentiated after SAH. Endothelin-1-induced Ca(2+) sensitization became less sensitive to inhibitors of Rho-associated coiled-coil protein kinase (ROCK) and protein kinase C (PKC) after SAH. The expression of PKCα, ROCK2, PKC-potentiated phosphatase inhibitor of 17 kDa (CPI-17) and myosin phosphatase target subunit 1 (MYPT1) was upregulated, and the level of phosphorylation of CPI-17 and MYPT1 was elevated after SAH. This study demonstrated for the first time that the Ca(2+)-sensitizing effect of ET-1 on myofilaments is potentiated after SAH. The increased expression and activity of PKCα, ROCK2, CPI-17, and MYPT1, as well as the upregulation of ET(A) receptor expression are suggested to underlie the enhanced and prolonged Ca(2+) sensitization induced by ET-1.
蛛网膜下腔出血(SAH)后脑血管痉挛的发生与血管平滑肌收缩力增强密切相关,肌球蛋白丝对钙离子的敏感性是平滑肌收缩力的主要决定因素。我们应用兔 SAH 模型研究了 SAH 后内皮素-1(ET-1)的钙增敏作用变化及其机制。SAH 后,基底动脉对 ET-1 的收缩反应增强,内皮素 A 受体(ET(A)受体)表达上调。在α-毒素通透的标本中,SAH 后 ET-1 诱导的收缩增强且持续时间延长,提示 ET-1 诱导的钙增敏作用增强。SAH 后 ET-1 诱导的钙增敏作用对 Rho 相关卷曲螺旋蛋白激酶(ROCK)和蛋白激酶 C(PKC)抑制剂的敏感性降低。PKCα、ROCK2、PKC 增强型磷酸酶抑制剂 17kDa(CPI-17)和肌球蛋白磷酸酶靶亚单位 1(MYPT1)的表达上调,SAH 后 CPI-17 和 MYPT1 的磷酸化水平升高。本研究首次证实,SAH 后 ET-1 对肌球蛋白丝的钙增敏作用增强。PKCα、ROCK2、CPI-17、MYPT1 的表达增加和活性增强,以及 ET(A)受体表达上调,可能是 ET-1 诱导的钙增敏作用增强和持续的原因。